DPLDIPNA PHARMACHEM LIMITED

BSE · Healthcare · Small Cap · Mkt cap ₹900M · Vol 17.37M

₹5,119.82

▼ -0.22% today

Fetching live price…

🏛️ Member of:BSE AllcapBSE SmallCap

God's Eye forensics

Accounting quality and solvency screens. Anything that can't be computed from available filings data is left blank rather than estimated.

Piotroski F-Score

5/5

5

5 of 5 financial-health checks passed (4 checks need data this provider doesn't publish).

Altman Z-Score

Insufficient data

—

Needs total assets, operating profit and debt — not published for this listing yet.

Beneish (earnings quality)

Insufficient data

—

The full manipulation model needs two years of receivables, depreciation and accrual data, which isn't published for this listing.

Scores are free. The criteria-by-criteria breakdown — exactly which checks this company failed — is part of DeepScreen Pro.

Fundamental breakdown — raw ratios are free · fetching live data — showing modeled estimates for now

P/E Ratio (TTM)

Modeled

22.9x

Fairly priced

Contextual insight — DeepScreen Pro

PEG Ratio

Modeled

0.80

Undervalued vs. growth

Contextual insight — DeepScreen Pro

P/S Ratio

Modeled

4.90x

Moderate

Contextual insight — DeepScreen Pro

P/B Ratio

Modeled

9.46x

Typical for the sector

Contextual insight — DeepScreen Pro

EV/Revenue

Modeled

6.07x

Typical for the sector

Contextual insight — DeepScreen Pro

EV/EBITDA

Modeled

16.9x

Fair

Contextual insight — DeepScreen Pro

ROE

Modeled

41.3%

Excellent shareholder returns

Contextual insight — DeepScreen Pro

ROA

Modeled

29.7%

Strong for asset-light

Contextual insight — DeepScreen Pro

ROCE

Modeled

33.1%

High-quality compounder

Contextual insight — DeepScreen Pro

Debt / Equity

Modeled

0.04x

Conservative balance sheet

Contextual insight — DeepScreen Pro

LT Debt / Equity

Modeled

0.02x

Very low structural debt

Contextual insight — DeepScreen Pro

Payout Ratio

Modeled

35%

Ideal balance — sustainable with room to reinvest

Contextual insight — DeepScreen Pro

Operating Leverage

Modeled

1.82x

Good upside gearing

Contextual insight — DeepScreen Pro

Company financials

EPS (TTM): ₹223.57
Revenue (TTM): ₹180M
Net margin: 21.4%
EBITDA margin: 35.9%
Earnings growth: 28.8%
Dividend yield: 1.53%
Payout ratio: 35%
Debt / equity: 0.04x

Live data hasn't loaded yet — figures shown are DeepScreen's modeled estimates.

DPL live news

LIVE

Loading live headlines…